Eastman Chemical (EMN) reported $2.51 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 9.9%. EPS of $1.97 for the same period compares to $1.60 a year ago.

The reported revenue represents a surprise of +6.16% over the Zacks Consensus Estimate of $2.37 billion. With the consensus EPS estimate being $1.80, the EPS surprise was +9.44%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Additives & Functional Products: $807 million versus the four-analyst average estimate of $772.01 million. The reported number represents a year-over-year change of +4.9%.
  • Net Sales- Fibers: $243 million versus the four-analyst average estimate of $249.74 million. The reported number represents a year-over-year change of -11.3%.
  • Net Sales- Chemical Intermediates: $643 million versus the four-analyst average estimate of $513.13 million. The reported number represents a year-over-year change of +38.9%.
  • Net Sales- Advanced Materials: $817 million versus the four-analyst average estimate of $810.28 million. The reported number represents a year-over-year change of +5.2%.
  • Net Sales- Other: $3 million versus $3.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -25% change.
  • Adjusted EBIT- Additives & Functional Products: $151 million versus $137.34 million estimated by four analysts on average.
  • Adjusted EBIT- Advanced Materials: $109 million versus $106.75 million estimated by four analysts on average.
  • Adjusted EBIT- Chemical Intermediates: $58 million versus the four-analyst average estimate of $36.79 million.
  • Adjusted EBIT- Other: $-34 million versus $-37.71 million estimated by four analysts on average.
  • Adjusted EBIT- Fibers: $36 million versus the four-analyst average estimate of $50.12 million.

View all Key Company Metrics for Eastman Chemical here>>>

Shares of Eastman Chemical have returned +0.3% over the past month versus the Zacks S&P 500 composite's -1.5% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

Eastman Chemical Company (EMN): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research